Yuanfa Yao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yuanfa Yao has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- Yingke Xu
Zhejiang University
5 shared publications - Hanbing Li
Department of Pharmaceutical Sciences, Institute of Pharmacology, Zhejiang University of Technology, Hangzhou, China
4 shared publications Li-Fang Zhu
Department of Biomedical Engineering, Key Laboratory of Ministry of Education, Zhejiang University, Hangzhou 310027, PR China; Zhejiang Provincial Key Laboratory of Cardio-Cerebral Vascular Detection Technology and Medicinal Effectiveness Appraisal, Zhejiang University, Hangzhou 310027, PR China
2 shared publications- Xiaohan Qian
Division of Gastroenterology and Hepatology Stanford University Medical Center Palo Alto California USA
2 shared publications - Xinyi Wang
Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Thorac Surg, Shanghai, Peoples R China
2 shared publications Xuqin Zhao
Institute of Pharmacology, College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou, Zhejiang 310014, China
2 shared publications
Latest Publications
- Open Access
- 29 July 2024
- Published by Wiley in Advanced Science
- Vol. 11 (36) , e2403026
Optogenetic Strategies for Optimizing the Performance of Phospholipids Biosensors
High‐performance biosensors play a crucial role in elucidating the intricate spatiotemporal regulatory roles and dynamics of membrane phospholipids. However, enhancing the sensitivity and imaging performance remains a significant challenge. Here, optogenetic‐based strategies are presented to optimize phospholipid biosensors. These strategies involves presequestering unbound biosensors in the cell nucleus and regulating their cytosolic levels with blue light to minimize background signal interference in phospholipid detection, particularly under conditions of high expression levels of biosensor. Furthermore, optically controlled phase separation and the SunTag system are employed to generate punctate probes for substrate detection, thereby amplifying biosensor signals and enhancing visualization of the detection process. These improved phospholipid biosensors hold great potential for enhancing the understanding of the spatiotemporal dynamics and regulatory roles of membrane lipids in live cells and the methodological insights in this study might be valuable for developing other high‐performance biosensors.
- 29 July 2024
- Published by Wiley in Advanced Science
- Vol. 11 (36) , e2403026
Open AccessOptogenetic Strategies for Optimizing the Performance of Phospholipids Biosensors
High‐performance biosensors play a crucial role in elucidating the intricate spatiotemporal regulatory roles and dynamics of membrane phospholipids. However, enhancing the sensitivity and imaging performance remains a significant challenge. Here, optogenetic‐based strategies are presented to optimize phospholipid biosensors. These strategies involves presequestering unbound biosensors in the cell nucleus and regulating their cytosolic levels with blue light to minimize background signal interference in phospholipid detection, particularly under conditions of high expression levels of biosensor. Furthermore, optically controlled phase separation and the SunTag system are employed to generate punctate probes for substrate detection, thereby amplifying biosensor signals and enhancing visualization of the detection process. These improved phospholipid biosensors hold great potential for enhancing the understanding of the spatiotemporal dynamics and regulatory roles of membrane lipids in live cells and the methodological insights in this study might be valuable for developing other high‐performance biosensors.
- Open Access
- 1 September 2023
- Published by KEAI Publishing in Genes & Diseases
- Vol. 10 (5) , 1787-1790
Novel function of biguanides in inhibition of phospholipase D1 expression via a translational mechanism in cancer cells
- 1 September 2023
- Published by KEAI Publishing in Genes & Diseases
- Vol. 10 (5) , 1787-1790
Open AccessNovel function of biguanides in inhibition of phospholipase D1 expression via a translational mechanism in cancer cells
- 1 January 2021
- Published by Elsevier in Progress in Lipid Research
- Vol. 81, 101070
Structural insights into phospholipase D function
- 1 January 2021
- Published by Elsevier in Progress in Lipid Research
- Vol. 81, 101070
Structural insights into phospholipase D function
- 19 February 2020
- Published by Wiley in Biological Reviews
- Vol. 95 (4) , 911-935
Phospholipase D as a key modulator of cancer progression
The phospholipase D (PLD) family has a ubiquitous expression in cells. PLD isoforms (PLDs) and their hydrolysate phosphatidic acid (PA) have been demonstrated to engage in multiple stages of cancer progression. Aberrant expression of PLDs, especially PLD1 and PLD2, has been detected in various cancers. Inhibition or elimination of PLDs activity has been shown to reduce tumour growth and metastasis. PLDs and PA also serve as downstream effectors of various cell‐surface receptors, to trigger and regulate propagation of intracellular signals in the process of tumourigenesis and metastasis. Here, we discuss recent advances in understanding the functions of PLDs and PA in discrete stages of cancer progression, including cancer cell growth, invasion and migration, and angiogenesis, with special emphasis on the tumour‐associated signalling pathways mediated by PLDs and PA and the functional importance of PLDs and PA in cancer therapy.
- 19 February 2020
- Published by Wiley in Biological Reviews
- Vol. 95 (4) , 911-935
Phospholipase D as a key modulator of cancer progression
The phospholipase D (PLD) family has a ubiquitous expression in cells. PLD isoforms (PLDs) and their hydrolysate phosphatidic acid (PA) have been demonstrated to engage in multiple stages of cancer progression. Aberrant expression of PLDs, especially PLD1 and PLD2, has been detected in various cancers. Inhibition or elimination of PLDs activity has been shown to reduce tumour growth and metastasis. PLDs and PA also serve as downstream effectors of various cell‐surface receptors, to trigger and regulate propagation of intracellular signals in the process of tumourigenesis and metastasis. Here, we discuss recent advances in understanding the functions of PLDs and PA in discrete stages of cancer progression, including cancer cell growth, invasion and migration, and angiogenesis, with special emphasis on the tumour‐associated signalling pathways mediated by PLDs and PA and the functional importance of PLDs and PA in cancer therapy.
- 1 November 2019
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 519 (2) , 253-260
Sec3 knockdown inhibits TGF-β induced epithelial-mesenchymal transition through the down-regulation of Akt phosphorylation in A549 cells
- 1 November 2019
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 519 (2) , 253-260
Sec3 knockdown inhibits TGF-β induced epithelial-mesenchymal transition through the down-regulation of Akt phosphorylation in A549 cells
- 1 September 2019
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 137, 105002
A novel core-shell nanofiber drug delivery system intended for the synergistic treatment of melanoma
- 1 September 2019
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 137, 105002
A novel core-shell nanofiber drug delivery system intended for the synergistic treatment of melanoma
- 1 September 2019
- Published by Elsevier in Process Biochemistry
- Vol. 84, 103-111
Development of Ganoderma lucidum spore powder based proteoglycan and its application in hyperglycemic, antitumor and antioxidant function
- 1 September 2019
- Published by Elsevier in Process Biochemistry
- Vol. 84, 103-111
Development of Ganoderma lucidum spore powder based proteoglycan and its application in hyperglycemic, antitumor and antioxidant function
- 1 March 2019
- Published by Elsevier in Optics Communications
- Vol. 434, 145-151
Assessment of tissues’ inhomogeneous optical properties based on a portable microscope under partially coherent illumination
- 1 March 2019
- Published by Elsevier in Optics Communications
- Vol. 434, 145-151
Assessment of tissues’ inhomogeneous optical properties based on a portable microscope under partially coherent illumination
- 1 August 2018
- Published by Canadian Science Publishing in Canadian Journal of Physiology and Pharmacology
- Vol. 96 (8) , 765-771
Coumarins improved type 2 diabetes induced by high-fat diet and streptozotocin in mice via antioxidation
Coumarins extensively exist in plants and are utilized against diabetes in some folk medicines. Recent studies have demonstrated that oxidative stress plays a crucial role in the etiology and pathogenesis of diabetes mellitus. We investigated the antioxidant ability of 3 coumarins (osthole, esculin, and fraxetin) in type 2 diabetes. After being fed a high-fat diet, ICR mice were exposed to low doses of streptozotocin and then treated with experimental coumarins for 5 weeks. We found osthole, esculin, and metformin significantly lowered fasting blood glucose, HOMA-IR, and 3 blood lipids (total cholesterol, total triglyceride, free fatty acids), and increased insulin levels, while fraxetin only enhanced insulin levels and lessened free fatty acids. Both osthole and esculin had antioxidative effects in pancreas through elevating the activities of glutathione peroxidase, catalase, and superoxide dismutase; fraxetin, however, merely heightened catalase activity. By contrast, 3 coumarins significantly increased those antioxidase activities in liver. Hematoxylin and eosin staining revealed 3 coumarins, especially osthole, attenuated cellular derangement, blurry fringes of hepatic sinusoid and extensive vacuolization due to hepatocellular lipid accumulation, and lessened inflammatory infiltration in pancreas. The glomerular and islet structure of diabetic mice were improved, with reduced mesangial matrix and glomerular basement membrane thickening. Therefore, our study supports that coumarins could be promising candidates against type 2 diabetes through antioxidative mechanisms.
- 1 August 2018
- Published by Canadian Science Publishing in Canadian Journal of Physiology and Pharmacology
- Vol. 96 (8) , 765-771
Coumarins improved type 2 diabetes induced by high-fat diet and streptozotocin in mice via antioxidation
Coumarins extensively exist in plants and are utilized against diabetes in some folk medicines. Recent studies have demonstrated that oxidative stress plays a crucial role in the etiology and pathogenesis of diabetes mellitus. We investigated the antioxidant ability of 3 coumarins (osthole, esculin, and fraxetin) in type 2 diabetes. After being fed a high-fat diet, ICR mice were exposed to low doses of streptozotocin and then treated with experimental coumarins for 5 weeks. We found osthole, esculin, and metformin significantly lowered fasting blood glucose, HOMA-IR, and 3 blood lipids (total cholesterol, total triglyceride, free fatty acids), and increased insulin levels, while fraxetin only enhanced insulin levels and lessened free fatty acids. Both osthole and esculin had antioxidative effects in pancreas through elevating the activities of glutathione peroxidase, catalase, and superoxide dismutase; fraxetin, however, merely heightened catalase activity. By contrast, 3 coumarins significantly increased those antioxidase activities in liver. Hematoxylin and eosin staining revealed 3 coumarins, especially osthole, attenuated cellular derangement, blurry fringes of hepatic sinusoid and extensive vacuolization due to hepatocellular lipid accumulation, and lessened inflammatory infiltration in pancreas. The glomerular and islet structure of diabetic mice were improved, with reduced mesangial matrix and glomerular basement membrane thickening. Therefore, our study supports that coumarins could be promising candidates against type 2 diabetes through antioxidative mechanisms.
- Open Access
- 3 July 2017
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 69 (10) , 1253-1264
Coumarins as potential antidiabetic agents
Objectives: Even with great advances in modern medicine and therapeutic agent development, the search for effective antidiabetic drugs remains challenging. Coumarins are secondary metabolites found widely in nature plants and used mainly in anticoagulation and antithrombotic therapy. Over the past two decades, however, there has been an increasing body of literatures related to the effects of coumarins and their derivatives on diabetes and its complications. This review aimed to focus on research findings concerning the effects of coumarins against diabetes and its complications using in-vitro and in-vivo animal models, and also to discuss cellular and molecular mechanisms underlying these effects. Key findings: The search for new coumarins against diabetes and it complications, either isolated from traditional medicine or chemically synthesized, has been constantly expanding. The cellular and molecular mechanisms involved include protecting pancreatic beta cells from damage, improving abnormal insulin signalling, reducing oxidative stress/inflammation, activating AMP-activated protein kinase (AMPK), inhibiting α-glucosidases and ameliorating diabetic complications. Conclusions: The effects and mechanisms of coumarins and their derivatives upon diabetes and its complications are discussed in current review. Further investigations remain to be carried out to develop a promising antidiabetic agent based on coumarin cores.
- 3 July 2017
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 69 (10) , 1253-1264
Open AccessCoumarins as potential antidiabetic agents
Objectives: Even with great advances in modern medicine and therapeutic agent development, the search for effective antidiabetic drugs remains challenging. Coumarins are secondary metabolites found widely in nature plants and used mainly in anticoagulation and antithrombotic therapy. Over the past two decades, however, there has been an increasing body of literatures related to the effects of coumarins and their derivatives on diabetes and its complications. This review aimed to focus on research findings concerning the effects of coumarins against diabetes and its complications using in-vitro and in-vivo animal models, and also to discuss cellular and molecular mechanisms underlying these effects. Key findings: The search for new coumarins against diabetes and it complications, either isolated from traditional medicine or chemically synthesized, has been constantly expanding. The cellular and molecular mechanisms involved include protecting pancreatic beta cells from damage, improving abnormal insulin signalling, reducing oxidative stress/inflammation, activating AMP-activated protein kinase (AMPK), inhibiting α-glucosidases and ameliorating diabetic complications. Conclusions: The effects and mechanisms of coumarins and their derivatives upon diabetes and its complications are discussed in current review. Further investigations remain to be carried out to develop a promising antidiabetic agent based on coumarin cores.